Mengwan Wu

585 total citations
19 papers, 415 citations indexed

About

Mengwan Wu is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Mengwan Wu has authored 19 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Mengwan Wu's work include Glioma Diagnosis and Treatment (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Immune cells in cancer (3 papers). Mengwan Wu is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Immune cells in cancer (3 papers). Mengwan Wu collaborates with scholars based in China, Hong Kong and Philippines. Mengwan Wu's co-authors include Qiang Zuo, Lihong Guo, Jing Guo, Jing Guo, Jing Liu, Sheng Peng, Chuan Xu, Qianying Wu, Changqie Pan and Ying Shi and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Mengwan Wu

18 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengwan Wu China 11 184 148 90 77 71 19 415
Min‐Sun Jin South Korea 13 126 0.7× 165 1.1× 85 0.9× 77 1.0× 119 1.7× 32 457
Boju Pan China 10 188 1.0× 133 0.9× 55 0.6× 34 0.4× 93 1.3× 33 421
Giuseppe Nicolò Fanelli Italy 14 237 1.3× 209 1.4× 198 2.2× 133 1.7× 58 0.8× 46 630
Hyun Min Koh South Korea 12 97 0.5× 200 1.4× 89 1.0× 125 1.6× 51 0.7× 41 427
Hae Min Jeong South Korea 11 167 0.9× 174 1.2× 118 1.3× 145 1.9× 52 0.7× 19 457
Ondina Popescu Italy 13 139 0.8× 190 1.3× 86 1.0× 64 0.8× 38 0.5× 24 430
Yunxiang Zhang China 15 200 1.1× 200 1.4× 121 1.3× 62 0.8× 40 0.6× 42 554
Ruifei Xie China 9 186 1.0× 167 1.1× 106 1.2× 109 1.4× 126 1.8× 16 449
Hong Ling China 16 240 1.3× 190 1.3× 187 2.1× 80 1.0× 66 0.9× 33 583
Jialiang Shao China 15 131 0.7× 196 1.3× 105 1.2× 128 1.7× 69 1.0× 31 510

Countries citing papers authored by Mengwan Wu

Since Specialization
Citations

This map shows the geographic impact of Mengwan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengwan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengwan Wu more than expected).

Fields of papers citing papers by Mengwan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengwan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengwan Wu. The network helps show where Mengwan Wu may publish in the future.

Co-authorship network of co-authors of Mengwan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengwan Wu. A scholar is included among the top collaborators of Mengwan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengwan Wu. Mengwan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wu, Mengwan, et al.. (2024). Exosome‐transmitted podoplanin promotes tumor‐associated macrophage‐mediated immune tolerance in glioblastoma. CNS Neuroscience & Therapeutics. 30(3). e14643–e14643. 8 indexed citations
2.
Chen, Jian, et al.. (2024). Dual-Reference Source-Free Active Domain Adaptation for Nasopharyngeal Carcinoma Tumor Segmentation Across Multiple Hospitals. IEEE Transactions on Medical Imaging. 43(12). 4078–4090. 14 indexed citations
3.
Wu, Mengwan, Ying Shi, Yuyang Liu, et al.. (2023). A Human Adenovirus C Infection-Related Gene Panel for Predicting Survival and Treatment Responsiveness in Glioma Patients. World Neurosurgery. 183. e173–e186.
4.
Luo, Xiangde, Wenjun Liao, Yuan He, et al.. (2023). Deep learning-based accurate delineation of primary gross tumor volume of nasopharyngeal carcinoma on heterogeneous magnetic resonance imaging: A large-scale and multi-center study. Radiotherapy and Oncology. 180. 109480–109480. 27 indexed citations
5.
Tan, Tian, Qi Yang, Mengwan Wu, et al.. (2023). mRNA Vaccine - A New Cancer Treatment Strategy. Current Cancer Drug Targets. 23(9). 669–681. 15 indexed citations
6.
Liu, Yuyang, et al.. (2022). Comprehensive analysis of HHV‐6 and HHV‐7‐related gene signature in prognosis and response to temozolomide of glioma. Journal of Medical Virology. 95(1). e28285–e28285. 3 indexed citations
7.
Liao, Wenjun, Jinlan He, Xiangde Luo, et al.. (2022). Automatic Delineation of Gross Tumor Volume Based on Magnetic Resonance Imaging by Performing a Novel Semisupervised Learning Framework in Nasopharyngeal Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 113(4). 893–902. 16 indexed citations
8.
Wu, Mengwan, et al.. (2022). Macrophages in Glioblastoma Development and Therapy: A Double-Edged Sword. Life. 12(8). 1225–1225. 14 indexed citations
9.
Shi, Ying, Mengwan Wu, Yuyang Liu, et al.. (2022). Bottlenecks and opportunities in immunotherapy for glioma: a narrative review. SHILAP Revista de lepidopterología. 5(4). 151–162. 2 indexed citations
10.
Liu, Yuyang, Ying Shi, Mengwan Wu, et al.. (2022). Hypoxia‐induced polypoid giant cancer cells in glioma promote the transformation of tumor‐associated macrophages to a tumor‐supportive phenotype. CNS Neuroscience & Therapeutics. 28(9). 1326–1338. 27 indexed citations
11.
Shi, Ying, Mengwan Wu, Yuyang Liu, et al.. (2021). ITGA5 Predicts Dual-Drug Resistance to Temozolomide and Bevacizumab in Glioma. Frontiers in Oncology. 11. 769592–769592. 17 indexed citations
12.
13.
14.
Guo, Jing, Mengwan Wu, Lihong Guo, & Qiang Zuo. (2017). Pretreatment blood neutrophil/lymphocyte ratio is associated with metastasis and predicts survival in patients with pancreatic cancer. Bulletin du Cancer. 105(2). 146–154. 9 indexed citations
15.
Wu, Mengwan, Jing Guo, Lihong Guo, & Qiang Zuo. (2016). The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer. Tumor Biology. 37(9). 12525–12533. 84 indexed citations
16.
Liu, Jing, Changqie Pan, Lihong Guo, et al.. (2016). A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the Warburg effect via activation of the PI3K/AKT signaling pathway. Journal of Hematology & Oncology. 9(1). 76–76. 97 indexed citations
17.
Wu, Mengwan, Lihong Guo, & Qiang Zuo. (2016). [Correlation between cyclin-dependent kinase inhibitor p27kip1 and trastuzumab-resistance in gastric cancer].. PubMed. 41(5). 471–6. 1 indexed citations
18.
Zuo, Qiang, Jing Liu, Jingwen Zhang, et al.. (2015). Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance. Scientific Reports. 5(1). 11634–11634. 51 indexed citations
19.
Zuo, Qiang, Jing Liu, Jingwen Zhang, et al.. (2014). Regulation of trastuzumab resistance in gastric cancer by the PTEN gene, downstream AKT, and bypass IGF-IR signaling pathway.. Journal of Clinical Oncology. 32(15_suppl). e22079–e22079. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min‐Sun Jin Breakdown of academic impact, for papers by Boju Pan Breakdown of academic impact, for papers by Giuseppe Nicolò Fanelli Breakdown of academic impact, for papers by Hyun Min Koh Breakdown of academic impact, for papers by Hae Min Jeong Breakdown of academic impact, for papers by Ondina Popescu Breakdown of academic impact, for papers by Yunxiang Zhang Breakdown of academic impact, for papers by Ruifei Xie Breakdown of academic impact, for papers by Hong Ling Breakdown of academic impact, for papers by Jialiang Shao
Rankless by CCL
2026